Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Advances in Experimental Medicine and Biology
|
February 23, 1999
Plasmid DNA for clinical phase I and II studies. Large-scale cGMP manufacturing and quality assurance
M Schleef, J Schorr
Biotechniques
|
April 1, 1993
Cesium chloride or column preparation? An electron microscopical view of plasmid preparations
M Schleef, P Heimann
Developments in Biologicals
|
November 21, 2001
Plasmid DNA for pharmaceutical applications
M Schleef, T Schmidt, E Flaschel
Methods in Molecular Medicine
|
March 5, 2011
Production of Plasmid DNA in Industrial Quantities According to cGMP Guidelines
J Schorr, P Moritz, M Schleef
Annales De Dermatologie Et De Syphiligraphie
|
January 1, 1971
[Thoracoabdominobrachial and vulvar sclero-atrophic lichen]
S Sigal, A Pastel, Bouzamondo, et al.
Neuromuscular Disorders : NMD
|
May 1, 1994
Subtractive cDNA cloning as a tool to analyse secondary effects of a muscle disease. Characterization of affected genes in the myotonic ADR mouse
M Schleef, C Zühlke, F Schöffl, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
January 1, 1992
The structure of the mouse parvalbumin gene
M Schleef, C Zühlke, H Jockusch, et al.
Annals of the New York Academy of Sciences
|
November 27, 1995
Plasmid DNA for human gene therapy and DNA vaccines. Production and quality assurance
J Schorr, P Moritz, T Seddon, et al.
Methods in Molecular Medicine
|
March 5, 2011
DNA-Based Vaccination Primes Tumor-Rejecting T-Cell Responses
W Böhm, M Schleef, S Thoma, et al.
Analytical Biochemistry
|
October 21, 1999
Quantitative analysis of plasmid forms by agarose and capillary gel electrophoresis
T Schmidt, K Friehs, M Schleef, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Advances in Experimental Medicine and Biology
|
February 23, 1999
Plasmid DNA for clinical phase I and II studies. Large-scale cGMP manufacturing and quality assurance
M Schleef, J Schorr
Biotechniques
|
April 1, 1993
Cesium chloride or column preparation? An electron microscopical view of plasmid preparations
M Schleef, P Heimann
Developments in Biologicals
|
November 21, 2001
Plasmid DNA for pharmaceutical applications
M Schleef, T Schmidt, E Flaschel
Methods in Molecular Medicine
|
March 5, 2011
Production of Plasmid DNA in Industrial Quantities According to cGMP Guidelines
J Schorr, P Moritz, M Schleef
Annales De Dermatologie Et De Syphiligraphie
|
January 1, 1971
[Thoracoabdominobrachial and vulvar sclero-atrophic lichen]
S Sigal, A Pastel, Bouzamondo, et al.
Neuromuscular Disorders : NMD
|
May 1, 1994
Subtractive cDNA cloning as a tool to analyse secondary effects of a muscle disease. Characterization of affected genes in the myotonic ADR mouse
M Schleef, C Zühlke, F Schöffl, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
January 1, 1992
The structure of the mouse parvalbumin gene
M Schleef, C Zühlke, H Jockusch, et al.
Annals of the New York Academy of Sciences
|
November 27, 1995
Plasmid DNA for human gene therapy and DNA vaccines. Production and quality assurance
J Schorr, P Moritz, T Seddon, et al.
Methods in Molecular Medicine
|
March 5, 2011
DNA-Based Vaccination Primes Tumor-Rejecting T-Cell Responses
W Böhm, M Schleef, S Thoma, et al.
Analytical Biochemistry
|
October 21, 1999
Quantitative analysis of plasmid forms by agarose and capillary gel electrophoresis
T Schmidt, K Friehs, M Schleef, et al.
Page
of 3